Analyst Serge Belanger of Needham maintained a Buy rating on Liquidia Technologies (LQDA – Research Report), retaining the price target of ...

For the past 10 years, medications and inhalers began to help less and less with Rose Walsh’s breathing problems. Battling ...

I-Mab said it has paused the development of uliledlimab to focus on a Phase I trial of its lead candidate givastomig.

BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing the novel, selective AXL kinase inhibitor bemcentinib for lung cancer announced today that the first patient has been ...

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced the opening ...

Rising global interest in state-of-the-art bronchial biopsy devices highlights a pivotal shift toward simplified procedures ...

By distribution channel, in 2019, the franchise store segment accounted for the highest <a target=_blank href= ...